tirzepatide surmount 3 Further Cements Weight Loss Benefit in SURMOUNT-3 and SURMOUNT-4 Trials tirzepatide phase 3 study results

Compared with sulfonylureas, metformin as first-line therapy has beneficial effects on A1C, is weight neutral, does not cause hypoglycemia, and reduces cardiovascular mortality (97)

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

Mrz 2026 aus

This ensures your vitamin therapy is appropriate, safe, and effective

Research released by Eli Lilly reports that common side effects include nausea, constipation, diarrhea, vomiting, indigestion, abdominal pain, headache, bloating, fatigue, and hair loss

Not only did he report positive changes, but his tests also demonstrated clinical improvement in cognitive function, a reduction in biological age by almost 8 years, and a 0.14 kb increase in telomere length